OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex biologics. Improving these processes involves modifying various factors, including cell line engineering, media composition, and bioreactor conditions. A key goal is to increase antibody yield while minimizing production financi